Integrated Diagnostics Holdings plc (LON:IDHC)
London
· Delayed Price · Currency is GBP · Price in USD 0.3320
-0.0280 (-7.78%)
Apr 28, 2025, 1:52 PM BST
LON:IDHC Revenue
In the year 2024, Integrated Diagnostics Holdings had annual revenue of 5.72B EGP with 38.74% growth. Integrated Diagnostics Holdings had revenue of 1.61B in the quarter ending December 31, 2024, with 50.72% growth.
Revenue
5.72B EGP
Revenue Growth
+38.74%
P/S Ratio
1.75
Revenue / Employee
906.60K EGP
Employees
6,309
Market Cap
157.23M GBP
Revenue Chart
* This company reports financials in EGP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.72B | 1.60B | 38.74% |
| Dec 31, 2023 | 4.12B | 517.46M | 14.35% |
| Dec 31, 2022 | 3.61B | -1.62B | -31.00% |
| Dec 31, 2021 | 5.22B | 2.57B | 96.69% |
| Dec 31, 2020 | 2.66B | 429.77M | 19.30% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
Integrated Diagnostics Holdings News
- 5 months ago - Integrated Diagnostics Holdings PLC (LSE:IDHC) Q3 2024 Earnings Call Highlights: Strong Revenue ... - GuruFocus
- 5 months ago - Q3 2024 Integrated Diagnostics Holdings PLC Earnings Call Transcript - GuruFocus